We wanted to show that TrackMyTac® with its AI-based coaching can enable patients to both manage their dosing better and also maintain their adherence levels
We conducted a one year patient study to find out
The results are presented below.
TrackMyTac is also available on most browsers providing personalised data insights, along with day to day AI-based adherence coaching.
The chart shows the monthly Tacrolimus readings for a one year control group of 25 patients who interacted with their physician or nephrologist in order to take their medication regularly and on-time, twice daily.
In all cases the adherence coaching was irregular and ad hoc, depending on the patient's perceived need for help or coaching.
Overall patients' Adherence percentages were between 67% and 78% with average dose-time drift at ±27 minutes.
On average after 1 year, this group showed 48% less measured Tac level variability.
This chart shows the monthly Tacrolimus readings for a one year group of 27 patients who have continually used TrackMyTac for a year to manage their dosing intervals and continually improve their adherence levels.
In all cases the adherence coaching was provided by TrackMyTac in the form of daily dose feedback..
For this group, overall patients' Adherence percentages were between 78% and 91% with average dose-time drift at ±17 minutes.
On average after 1 year, this group showed 76% less measured Tac level variability.
